Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

9473	Companies
185396	Keywords
117753	Articles
99279	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 11/20/2025 at 13:05, 14 days 19 hours ago

Moderna Reveals Strategic Growth Plans and Pipeline Progress

Revenue Growth Financial Strategy Oncology Pipeline Manufacturing Network Vaccine Expansion
PRESS RELEASE

published on 11/20/2025 at 13:00, 14 days 19 hours ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Moderna, Inc. announces three-year business strategy with commercial growth drivers targeting up to 10% revenue growth in 2026. The company plans to expand its seasonal vaccine franchise and progress in oncology pipeline

Revenue Growth Business Strategy Moderna Oncology Pipeline Seasonal Vaccine
BRIEF

published on 11/19/2025 at 13:05, 15 days 19 hours ago

Moderna Strengthens U.S. Manufacturing with New Onshore Drug Production

MRNA Technology Moderna Job Creation U.S. Manufacturing Norwood Expansion
PRESS RELEASE

published on 11/19/2025 at 13:00, 15 days 19 hours ago

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities
Moderna expands U.S. production capabilities, onshores Drug Product manufacturing to enhance mRNA network, creating biomanufacturing jobs

Manufacturing Moderna MRNA Onshoring Biomanufacturing
BRIEF

published on 11/18/2025 at 13:05, 16 days 19 hours ago

Moderna to Present at Piper Sandler's Healthcare Conference

Investor Presentation MRNA Technology Moderna Healthcare Conference Piper Sandler
PRESS RELEASE

published on 11/18/2025 at 13:00, 16 days 19 hours ago

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
Moderna, Inc. announces participation in Piper Sandler's 37th Annual Healthcare Conference on December 2nd. Webcast available. Moderna revolutionizes mRNA medicine for disease treatment and prevention

Investor Relations MRNA Medicine Moderna Healthcare Conference Piper Sandler
BRIEF

published on 11/06/2025 at 13:05, 28 days 19 hours ago

Moderna Reports $1 Billion Revenue in Q3 2025 Amidst Narrowed 2025 Financial Projections

Financial Results COVID-19 Vaccine Revenue Decline Moderna Cost Efficiency
PRESS RELEASE

published on 11/06/2025 at 13:00, 28 days 19 hours ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed

Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF

published on 11/03/2025 at 13:05, 1 month 1 day ago

Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy

Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE

published on 11/03/2025 at 13:00, 1 month 1 day ago

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms

Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 10 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 15 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 45 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 40 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 45 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 14 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 15 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 39 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 44 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 44 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 45 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE